# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Sanofi is set to invest up to $1.6 billion in its Frankfurt insulin production site, marking a significant win for Germany'...
Cantor Fitzgerald analyst Louise Chen reiterates Eli Lilly and Co (NYSE:LLY) with a Overweight and maintains $885 price target.
Eli Lilly is up a remarkable 97.38% over the past year and 55.32% year-to-date. Strong technical indicators suggest continued m...
Novo Nordisk will limit initial sales of Wegovy in China to manage global supply and address the rising obesity rates in the wo...
Ben Cohen and Jerry Greenfield, the co-founders of Ben & Jerry's, are not worried about the impact of weight-loss drugs...